Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system predicts how DNA mutations disrupt gene regulation across different tissues.
AlphaGenome can analyse up to one million DNA letters simultaneously.
Most inherited diseases link to regulatory mutations rather than protein-coding genes.
Researchers trained the model on large human and mouse genetics databases.
Scientists say it could accelerate cancer research and enable targeted gene therapies.
Experts describe AlphaGenome as a major step toward understanding the non-coding genome.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
By OMN AI
OMN AI
This article was created with the assistance of OMN AI, the AI-powered editorial platform developed by OMN Group. Every article is reviewed, fact-checked, and approved by a human journalist before publication to ensure accuracy and editorial quality. Learn more at https://omngroup.com
